Cayenne Pepper and Fatty Liver: What the Evidence Says

Cayenne pepper and fatty liver disease is a topic of growing interest, with many people curious whether this common spice could support liver health. Cayenne pepper contains capsaicin, an active compound that has shown promise in preclinical research for its potential anti-inflammatory and metabolic effects. However, the evidence in humans remains limited, and cayenne pepper is not part of any NHS or NICE treatment pathway for fatty liver disease. This article explores what the science currently says, the risks of regular use, and what UK clinical guidelines actually recommend for managing fatty liver disease effectively.

What is fatty liver disease and how common is it in the UK?

Fatty liver disease, particularly MASLD, affects around one in three adults in the UK and is closely linked to obesity, type 2 diabetes and insulin resistance. Most people have no symptoms in early stages, making incidental detection common.

Fatty liver disease is a condition in which excess fat accumulates within liver cells, impairing normal liver function over time. It is broadly divided into two main types: metabolic dysfunction-associated steatotic liver disease (MASLD, previously known as non-alcoholic fatty liver disease or NAFLD) and alcohol-related liver disease (ALD). MASLD is the more prevalent form and is closely linked to obesity, type 2 diabetes, high cholesterol and insulin resistance. Note that NICE guidance (NG49) still uses the older NAFLD and NASH terminology, so you may encounter both sets of terms in clinical settings.^[1][2]

Fatty liver disease is extremely common in the UK. NHS and British Liver Trust sources estimate that MASLD affects around one in three adults in the UK to some degree, making it one of the most widespread chronic liver conditions in the country.^[4] Most people in the early stages experience no symptoms, which means the condition often goes undetected until it is identified incidentally during an ultrasound or blood test.

Without intervention, a proportion of people with MASLD progress to more serious stages, including metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, cirrhosis and, in some cases, liver cancer. Early identification and lifestyle modification remain the cornerstone of management.

If you have been told you may have fatty liver disease, your GP will usually arrange blood tests and may calculate a FIB-4 score (a simple index using age, liver enzyme levels and platelet count) to assess the likelihood of significant fibrosis.^[1][4] Depending on the result, further assessment with an Enhanced Liver Fibrosis (ELF) test or transient elastography (FibroScan) may be arranged, and referral to a hepatologist considered. You should seek prompt medical attention if you develop any of the following: yellowing of the skin or whites of the eyes (jaundice), dark urine or pale stools, swelling of the abdomen, vomiting blood or passing black tarry stools, or new confusion. These may indicate serious liver disease and require urgent assessment.

Can cayenne pepper actually help with liver health?

Cayenne pepper is not a proven medical treatment for fatty liver disease; its active compound capsaicin has shown preclinical interest but no NHS or NICE pathway recommends it for MASLD.

Cayenne pepper is not a proven medical treatment for fatty liver disease, but its active compound, capsaicin, has attracted scientific interest for its potential metabolic and anti-inflammatory properties. Capsaicin is a naturally occurring alkaloid found in chilli peppers, including cayenne, and it acts primarily by binding to the transient receptor potential vanilloid 1 (TRPV1) receptor, which is involved in pain signalling, thermogenesis and metabolic regulation.^[7][9]

Preclinical research suggests that capsaicin may influence several biological pathways relevant to liver health, including fat metabolism, oxidative stress and inflammatory signalling. These mechanisms are of interest because MASLD is characterised by hepatic fat accumulation, chronic low-grade inflammation and oxidative damage. However, interest in these mechanisms does not equate to clinical evidence of benefit in humans with fatty liver disease, and no NHS or NICE pathway recommends capsaicin or cayenne pepper for MASLD.

Cayenne pepper is widely consumed as a culinary spice and is generally considered safe in food quantities. Some people use it in supplement form, though the evidence base for supplementation in liver conditions remains limited. Dietary patterns that include a variety of anti-inflammatory foods, including spices, vegetables and whole grains, are broadly supported by nutritional guidance, but no single food or spice should be viewed as a substitute for evidence-based medical management. Anyone considering dietary changes to support liver health should discuss these with their GP or a registered dietitian.

What does the current research say about capsaicin and the liver?

Research into capsaicin and liver health is largely preclinical; animal studies show reduced hepatic fat and inflammation, but no well-powered human randomised controlled trial has confirmed clinical benefit for MASLD.

Current research into capsaicin and liver health is largely based on animal studies and in vitro (laboratory) experiments, with limited high-quality human clinical trial data available. In rodent models of fatty liver disease, capsaicin has been shown in several studies to reduce hepatic fat accumulation, lower markers of liver inflammation and decrease oxidative stress.^[7][8] Some preclinical work has also suggested that capsaicin may activate AMP-activated protein kinase (AMPK), an enzyme involved in energy regulation and fat metabolism within the liver.^[6][7]

A small number of human observational studies have explored associations between chilli pepper consumption and metabolic health outcomes, including liver enzyme levels. Some findings suggest a modest association between regular consumption and lower levels of alanine aminotransferase (ALT), a marker of liver cell damage. However, these studies cannot establish causation and are subject to confounding factors such as overall dietary quality and lifestyle. No well-powered randomised controlled trial in humans has yet confirmed a clinically meaningful benefit of capsaicin for MASLD; systematic reviews of the available evidence have consistently concluded that the data are insufficient to support clinical recommendations.

Capsaicin has also been investigated in preclinical settings for its potential role in reducing hepatic stellate cell activation, a process central to liver fibrosis.^[5] This work remains predominantly preclinical. Researchers have called for well-designed randomised controlled trials in humans before any clinical recommendations can be made.

In summary, while the mechanistic rationale for capsaicin's potential liver benefits is scientifically plausible, the evidence is not yet sufficient to support its use as a therapeutic intervention. Patients with fatty liver disease should not rely on cayenne pepper or capsaicin supplements in place of established treatments and lifestyle changes recommended by their clinical team.

Are there any risks or side effects of using cayenne pepper regularly?

Regular or high-dose cayenne pepper use can cause heartburn, nausea, diarrhoea and gastrointestinal irritation; supplements are unregulated by the MHRA and may interact with anticoagulants or antihypertensive medicines.

Cayenne pepper is safe for most people when consumed in typical culinary amounts, but regular use, particularly in supplement or concentrated extract form, carries some potential risks and side effects worth considering. The most commonly reported effects relate to gastrointestinal irritation, including:

• Heartburn and acid reflux

• Nausea or stomach discomfort

• Diarrhoea, particularly at higher doses

• Worsening of symptoms in people with irritable bowel syndrome (IBS) or peptic ulcer disease

If you experience severe or persistent gastrointestinal symptoms after using cayenne pepper supplements, stop taking them and contact your GP for advice.

Capsaicin supplements are not regulated as medicines in the UK. They are classified as food supplements and are therefore not subject to the same rigorous safety and efficacy standards as licensed medicines authorised by the MHRA.^[10] This means that product quality, purity and dose can vary considerably between brands, as set out in Food Standards Agency and Office for Product Safety and Standards (OPSS) guidance on food supplements.

There is also a theoretical concern that high doses of capsaicin could interact with certain medicines, including anticoagulants such as warfarin and some antihypertensive drugs, though robust clinical evidence for these interactions in humans is limited.^[11][9] People taking regular prescribed medication should speak to their GP or pharmacist before starting any supplement; your pharmacist can check for potential interactions using authoritative UK resources.

Pregnant or breastfeeding women are generally advised to avoid high-dose capsaicin supplements, as safety data in these groups is insufficient. If you are pregnant or breastfeeding and considering any supplement, discuss this with your GP or midwife first. Topical capsaicin products used for pain relief are a separate category and should not be confused with dietary or oral supplementation.

Suspected adverse reactions to food supplements can be reported to the MHRA via the Yellow Card scheme (https://yellowcard.mhra.gov.uk/), which accepts reports from both patients and healthcare professionals.

What do NHS guidelines recommend for managing fatty liver disease?

NICE guidance (NG49) recommends gradual weight loss of 7 to 10 per cent of body weight, a balanced diet, at least 150 minutes of weekly physical activity and alcohol reduction as the primary management strategies for MASLD.

NHS and NICE guidance for managing MASLD centres on sustained lifestyle modification rather than any specific food, supplement or spice. The most effective interventions supported by clinical evidence include weight loss, increased physical activity and dietary improvement. NICE guidance (NG49) recommends that people with MASLD aim for a gradual, sustained weight loss of around 7 to 10 per cent of body weight, as this has been shown to meaningfully reduce hepatic fat and inflammation.^[1][2]

Key NHS-recommended lifestyle measures include:

• Following a balanced, calorie-appropriate diet rich in vegetables, wholegrains, lean protein and healthy fats

• Reducing intake of ultra-processed foods, added sugars and saturated fats

• Engaging in at least 150 minutes of moderate-intensity physical activity per week, in line with UK Chief Medical Officers' adult physical activity guidelines

• Avoiding or significantly reducing alcohol consumption, in line with UK low-risk drinking guidelines (no more than 14 units per week, spread across three or more days), even in MASLD where alcohol is not the primary cause^[12][13]

• Managing associated conditions such as type 2 diabetes, hypertension and dyslipidaemia with appropriate medical treatment

For people with obesity-related MASLD who have not achieved sufficient weight loss through lifestyle changes alone, NICE has appraised certain weight-management medicines (including semaglutide 2.4 mg and tirzepatide) for the treatment of obesity. These are commissioned for obesity management, not as MASLD-specific therapies, and eligibility and availability are subject to local Integrated Care Board (ICB) commissioning decisions and individual clinical assessment.

Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, for those exploring clinically supervised options alongside lifestyle change. Weight-management medicines are only prescribed where clinically appropriate following a consultation.

Cayenne pepper and capsaicin are not part of any current NHS or NICE treatment pathway for fatty liver disease. Patients should discuss their individual management plan with their GP, hepatologist or a registered dietitian rather than relying on unproven dietary supplements.

Scientific References

1. Metabolic dysfunction-associated steatotic liver disease (MASLD): assessment and management (NG49).
2. Metabolic dysfunction-associated steatotic liver disease (MASLD): assessment and management (NG49) — full guideline PDF.
3. Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance.
4. Non-alcoholic fatty liver disease (NAFLD).
5. Inhibitory effects of capsaicin on hepatic stellate cells and liver fibrosis.
6. Combination of hydroxycitric acid and capsaicin regulates IRS-1/AMPK-mTOR-SREBP-1c signalling.
7. Obesity-Induced MASLD Is Reversed by Capsaicin via Hepatic TRPV1 Activation. Current Issues in Molecular Biology.
8. The effect of dietary curcumin and capsaicin on hepatic fetuin-A expression and fat accumulation in rats fed on a high-fat diet. Archives of Physiology and Biochemistry.
9. Final Assessment Report — Capsicum annuum L. var. minimum (Miller) Heiser and small-fruited varieties of Capsicum frutescens L., fructus.
10. Food supplements: guidance for businesses.
11. Warfarin — Interactions.
12. Alcohol units — calculating alcohol units.
13. Drink less alcohol — Better Health.
14. UK Chief Medical Officers' physical activity guidelines.
15. Physical activity guidelines for adults aged 19 to 64.
16. Semaglutide for managing overweight and obesity (TA875).
17. Tirzepatide for managing overweight and obesity (TA1026).

Frequently Asked Questions